This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. (ABBV) slid 2.87% to $229.51 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&amp;P 500 Index  rising 1.55% to 6,705.12 and the Dow Jones Industrial Average  rising 0.44% to 46,448.27.
AbbVie Inc. closed 6.25% short of its 52-week high of $244.81, which the company achieved on October 1st.
The stock underperformed when compared to some of its competitors Monday, as Johnson &amp; Johnson (JNJ) rose 1.05% to $206.05, Pfizer Inc. (PFE) rose 0.72% to $25.22, and Amgen Inc. (AMGN) fell 0.96% to $334.30.
Trading volume (9.7 M) eclipsed its 50-day average volume of 6.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 24, 2025.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
11-24-25 1631ET

ABBV

<p>AbbVie Inc.'s stock fell 2.87% to $229.51 on Monday, underperforming compared to competitors like Johnson & Johnson and Pfizer, which saw gains. The stock is 6.25% below its 52-week high. Trading volume was higher than average, with 9.7 million shares traded. The S&P 500 and Dow Jones both rose during the session.</p>

AbbVie Inc. Stock Underperforms Monday When Compared To Competitors